Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-23-000870

Director acquired 17,501 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Coleman Mark · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Exercise or conversion : show line 1 in the form +17,501 $1.30 $22,751 25,097 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-03 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −17,501 0 D
Loading xslF345X03/doc4.xml…